Social Pulse: Abiomed Inc (ABMD.OQ)
ABMD.OQ on NASDAQ Stock Exchange Global Select Market
25 Nov 2015
25 Nov 2015
Change (% chg)
- Goldman Sachs Will Hit $210 - Cramer's Lightning Round (11/10/15)
- ABIOMED (ABMD) Michael R. Minogue on Q2 2016 Results - Earnings Call Transcript
- ABIOMED (ABMD) Q2 2016 Results - Earnings Call Webcast
- Building A Hedged Portfolio Of Governance Metrics International's Top-Ranked Stocks
- Investing While Guarding Against Extensive Vertical Losses
- ABIOMED's (ABMD) CEO Michael Minogue on Q1 2016 Results - Earnings Call Transcript
- Glancy Binkow & Goldberg LLP Announces Lead Plaintiff Deadline in the Class Action Lawsuit AgainstAbiomed, Inc.
- Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Abiomed, Inc.
- Investor Alert: Following Food and Drug Administration Panel Vote, Hagens Berman Reminds Abiomed, Inc. Investors of Jan. 15, 2013, Lead Plaintiff Deadline in Class-Action Lawsuit
- FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category
- Milberg LLP Announces Pendency of Class Action Lawsuits Filed Against Abiomed, Inc. (ABMD) -- AbiomedLawsuit.com